Market Snapshot

BSE Sensex: 75237.99 -0.21%
BSE 500: 35236.5 -0.36%
BSE 200: 10986.48 -0.35%
BSE 100: 25051.12 -0.28%
BSE BANKEX: 60489.34 -0.77%
BSE IT: 26964.26 1.06%
Nifty 50: 23643.5 -0.19%
Nifty 500: 22531.15 -0.36%
Nifty 200: 13596.35 -0.36%
Nifty 100: 24572.15 -0.33%
Nifty Midcap 100: 60567.15 -0.45%
Nifty Small 100: 17882.6 -0.61%
Nifty IT: 27716.9 1.30%
Nifty PSU Bank: 8027.2 -1.80%

News:

Hindustan Copper posts PAT of ...
TD Power Systems ends higher a...
Gland Pharma Q4 PAT jumps 97% ...
ITC Hotels Q4 PAT jumps 23% Yo...
Nazara Technologies surges on ...

TechNVision Ventures Ltd Share Price – BSE
IT - Software, Small Cap

Invest

15 May 2026 | 03:59 PM

5,480.00

-19.00 (-0.35%)

Add to Watchlist

This awesome feature is still in our labs.
Set Alert

This awesome feature is still in our labs.

Outperforms Index

8.9%

Return (1Y)

Beaten BSE Sensex by 16.19%
More Volatile

3.07%

Standard Deviation (1Y)

Higher than BSE Sensex by 2.24%
Not so consistent

5/12

Months

underperformed BSE Sensex
AxisDirect View

No View

52 Week High-Low

8,124

3,431

News & Announcements

Solix Technologies partners with Symbiosis Medical College for Women
58 days ago
Solix Technologies partners with Symbiosis Medical College for Women

18 - Mar - 2026 12:00 | 58 days ago
Solix Technologies (an affiliate of TechNVision Ventures) announced the signing of a Memorandum of Understanding (MoU) with Symbiosis Center for Entrepreneurship & Innovation (SCE) in collaboration with Symbiosis Medical College for Women (SMCW,), to establish a Center of Excellence (CoE) in New Drug Development and Drug Repurposing.

The MoU was formalized during TAL HealthFest 2026, reinforcing the commitment of both institutions to advance innovation at the intersection of Artificial Intelligence, biomedical research, and translational medicine.

The Center of Excellence aims to integrate:
- Computational intelligence and Al-driven in-silico modeling
- Molecular validation frameworks
- In-vivo translational research
The initial focus areas will include:
- Alzheimer's disease
- PAMR (Priority Antimicrobial Resistant) pathogens
This collaboration brings together Solix's 25+ years of expertise in end-to-end data lifecycle management, governance, and Enterprise Al with SMCW's clinical, translational, and biomedical research strengths.
Powered by Capital Market - Live News
TechNVision Ventures consolidated net profit rises 172.79% in the December 2025 quarter
90 days ago

TechNVision Ventures consolidated net profit rises 172.79% in the December 2025 quarter

14 - Feb - 2026 12:00 | 90 days ago

Net profit of TechNVision Ventures rose 172.79% to Rs 3.71 crore in the quarter ended December 2025 as against Rs 1.36 crore during the previous quarter ended December 2024. Sales declined 8.13% to Rs 74.38 crore in the quarter ended December 2025 as against Rs 80.96 crore during the previous quarter ended December 2024.

Particulars Quarter Ended
Dec. 2025 Dec. 2024 % Var.

Sales 74.38 80.96 -8

OPM % 6.39 2.06 -

PBDT 4.62 2.16 114

PBT 3.78 1.60 136

NP 3.71 1.36 173

Powered by Capital Market - Live News
TechNVision Ventures to discuss results
97 days ago

TechNVision Ventures to discuss results

07 - Feb - 2026 12:00 | 97 days ago

TechNVision Ventures will hold a meeting of the Board of Directors of the Company on 13 February 2026.
Powered by Capital Market - Live News
TechNVision Ventures reports consolidated net profit of Rs 0.71 crore in the September 2025 quarter
181 days ago

TechNVision Ventures reports consolidated net profit of Rs 0.71 crore in the September 2025 quarter

15 - Nov - 2025 12:00 | 181 days ago

Net profit of TechNVision Ventures reported to Rs 0.71 crore in the quarter ended September 2025 as against net loss of Rs 2.58 crore during the previous quarter ended September 2024. Sales rose 29.30% to Rs 71.23 crore in the quarter ended September 2025 as against Rs 55.09 crore during the previous quarter ended September 2024.

Particulars Quarter Ended
Sep. 2025 Sep. 2024 % Var.

Sales 71.23 55.09 29

OPM % 3.24 -3.45 -

PBDT 2.21 -1.75 LP

PBT 1.42 -2.27 LP

NP 0.71 -2.58 LP

Powered by Capital Market - Live News

Price vs Volume

Stock Trivia

TechNVision Ventures Ltd has been the 2nd best in 3 years performance among stocks in IT - Software Sector
TechNVision Ventures Ltd has the Lowesr P/E ratio according to FY 202503 data among stocks in IT - Software Sector
TechNVision Ventures Ltd has the highest P/B ratio according to FY 202503 data among stocks in IT - Software Sector
TechNVision Ventures Ltd has the Lowesr P/B ratio according to FY 202503 data among stocks in IT - Software Sector

Peer Comparison on Risk - Return

Thanks for Liking, Please spread your love by sharing...

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	74.38	80.96	-8
OPM %	6.39	2.06	-
PBDT	4.62	2.16	114
PBT	3.78	1.60	136
NP	3.71	1.36	173

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	71.23	55.09	29
OPM %	3.24	-3.45	-
PBDT	2.21	-1.75	LP
PBT	1.42	-2.27	LP
NP	0.71	-2.58	LP

General Notifications

My Notifications

Research Notifications

TechNVision Ventures Ltd Share Price – BSE IT - Software, Small Cap

5,480.00 -19.00 (-0.35%)

News & Announcements

Price vs Volume

Stock Trivia

TechNVision Ventures Ltd Share Price – BSE
IT - Software, Small Cap

5,480.00

-19.00 (-0.35%)